US · Healthcare

Eton Pharmaceuticals Inc (ETON)

Drug Manufacturers - Specialty & Generic

Eton Pharmaceuticals Inc (ETON) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ETON

P/E ratio

18.00

Eton Pharmaceuticals Inc (ETON) — FAQ

What is ETON's P/E ratio?

The price-to-earnings (P/E) ratio for Eton Pharmaceuticals Inc (ETON) is 18.00 (data as of 2026-05-23).

Does Eton Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Eton Pharmaceuticals Inc (ETON). Check the MyAverix Finance app for the latest dividend data.

What sector is Eton Pharmaceuticals Inc in?

Eton Pharmaceuticals Inc (ETON) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ETON listed on?

ETON is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)